63.26
-0.14
(-0.22%)
At close: January 31 at 3:28:18 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 19 | 19 | 22 | 21 |
| Avg. Estimate | 3.86B | 3.99B | 16.31B | 17.83B |
| Low Estimate | 3.8B | 3.8B | 16.03B | 15.27B |
| High Estimate | 3.94B | 4.24B | 17.17B | 21.48B |
| Year Ago Sales | 3.46B | 3.76B | 13B | 16.31B |
| Sales Growth (year/est) | 11.60% | 5.96% | 25.40% | 9.37% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| WDC.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Neutral to Neutral | 1/31/2025 |
| Maintains | UBS: Neutral to Neutral | 1/30/2025 |
| Maintains | Citigroup: Buy to Buy | 1/30/2025 |
| Maintains | Baird: Outperform to Outperform | 1/30/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/30/2025 |
| Maintains | Susquehanna: Neutral to Neutral | 1/30/2025 |